TELA Bio (TELA) Competitors $1.97 +0.12 (+6.49%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$1.94 -0.03 (-1.78%) As of 06/27/2025 05:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TELA vs. ZIMV, SMTI, TCMD, STIM, NVRO, TLSI, SGHT, BWAY, DRTS, and SKINShould you be buying TELA Bio stock or one of its competitors? The main competitors of TELA Bio include ZimVie (ZIMV), Sanara MedTech (SMTI), Tactile Systems Technology (TCMD), Neuronetics (STIM), Nevro (NVRO), TriSalus Life Sciences (TLSI), Sight Sciences (SGHT), Brainsway (BWAY), Alpha Tau Medical (DRTS), and Beauty Health (SKIN). These companies are all part of the "medical equipment" industry. TELA Bio vs. Its Competitors ZimVie Sanara MedTech Tactile Systems Technology Neuronetics Nevro TriSalus Life Sciences Sight Sciences Brainsway Alpha Tau Medical Beauty Health TELA Bio (NASDAQ:TELA) and ZimVie (NASDAQ:ZIMV) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation. Is TELA or ZIMV more profitable? ZimVie has a net margin of -4.40% compared to TELA Bio's net margin of -61.00%. ZimVie's return on equity of 5.53% beat TELA Bio's return on equity.Company Net Margins Return on Equity Return on Assets TELA Bio-61.00% -402.45% -62.73% ZimVie -4.40%5.53%2.84% Do insiders & institutionals believe in TELA or ZIMV? 94.4% of TELA Bio shares are held by institutional investors. Comparatively, 95.6% of ZimVie shares are held by institutional investors. 4.7% of TELA Bio shares are held by insiders. Comparatively, 3.0% of ZimVie shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more volatility & risk, TELA or ZIMV? TELA Bio has a beta of 0.78, suggesting that its share price is 22% less volatile than the S&P 500. Comparatively, ZimVie has a beta of 2.1, suggesting that its share price is 110% more volatile than the S&P 500. Does the media prefer TELA or ZIMV? In the previous week, ZimVie had 3 more articles in the media than TELA Bio. MarketBeat recorded 4 mentions for ZimVie and 1 mentions for TELA Bio. TELA Bio's average media sentiment score of 1.87 beat ZimVie's score of 0.62 indicating that TELA Bio is being referred to more favorably in the media. Company Overall Sentiment TELA Bio Very Positive ZimVie Positive Do analysts recommend TELA or ZIMV? TELA Bio currently has a consensus price target of $7.25, suggesting a potential upside of 268.02%. ZimVie has a consensus price target of $16.33, suggesting a potential upside of 76.39%. Given TELA Bio's stronger consensus rating and higher probable upside, equities research analysts plainly believe TELA Bio is more favorable than ZimVie.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TELA Bio 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75ZimVie 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.67 Which has better earnings & valuation, TELA or ZIMV? ZimVie has higher revenue and earnings than TELA Bio. ZimVie is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTELA Bio$69.30M1.12-$37.84M-$1.41-1.40ZimVie$449.75M0.57-$25.83M-$0.71-13.04 SummaryZimVie beats TELA Bio on 10 of the 17 factors compared between the two stocks. Get TELA Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TELA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TELA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TELA vs. The Competition Export to ExcelMetricTELA BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$77.92M$2.84B$5.47B$8.93BDividend YieldN/A2.48%5.32%4.15%P/E Ratio-1.4021.0326.2119.67Price / Sales1.12281.84387.56105.07Price / CashN/A42.8636.4056.84Price / Book2.747.207.875.43Net Income-$37.84M-$55.15M$3.16B$249.20M7 Day Performance19.39%0.76%3.10%3.99%1 Month Performance44.85%4.39%4.62%4.82%1 Year Performance-58.09%-0.74%31.74%17.00% TELA Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TELATELA Bio3.2793 of 5 stars$1.97+6.5%$7.25+268.0%-58.1%$77.92M$69.30M-1.40120ZIMVZimVie2.4993 of 5 stars$8.65-1.6%$16.33+88.8%-49.3%$244.78M$449.75M-12.181,770News CoverageAnalyst UpgradeSMTISanara MedTech2.2035 of 5 stars$27.82+2.0%$49.50+77.9%+0.7%$242.46M$86.67M-20.7660Positive NewsTCMDTactile Systems Technology3.2812 of 5 stars$10.17+2.0%$16.00+57.3%-13.4%$231.79M$292.98M15.411,037STIMNeuronetics2.5284 of 5 stars$3.43-0.9%$5.50+60.3%+96.1%$227.74M$74.89M-2.62180NVRONevro0.1666 of 5 stars$5.85+0.1%$5.36-8.3%-30.6%$224.32M$408.52M-3.091,090News CoverageTLSITriSalus Life Sciences3.1169 of 5 stars$5.29-5.4%$10.75+103.2%-3.6%$211.52M$29.43M-4.72106SGHTSight Sciences1.1534 of 5 stars$4.34+6.9%$4.10-5.5%-35.5%$209.88M$79.87M-4.43210News CoveragePositive NewsAnalyst UpgradeBWAYBrainsway1.4311 of 5 stars$11.49+5.3%$14.25+24.0%+117.8%$206.14M$41.02M57.45120News CoverageDRTSAlpha Tau Medical2.5181 of 5 stars$2.98+2.8%$8.00+168.5%+17.8%$204.10MN/A-6.4880News CoverageSKINBeauty Health0.3096 of 5 stars$1.93+19.9%$1.42-26.6%+1.6%$202.85M$334.30M-4.711,030Trending NewsHigh Trading Volume Related Companies and Tools Related Companies ZimVie Competitors Sanara MedTech Competitors Tactile Systems Technology Competitors Neuronetics Competitors Nevro Competitors TriSalus Life Sciences Competitors Sight Sciences Competitors Brainsway Competitors Alpha Tau Medical Competitors Beauty Health Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TELA) was last updated on 6/29/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TELA Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TELA Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
